VIEMED HEALTHCARE, INC.VMDEarnings & Financial Report
Nasdaq
VMD Q3 2025 Key Financial Metrics
Revenue
$71.9M
Gross Profit
$41.3M
Operating Profit
$5.6M
Net Profit
$3.5M
Gross Margin
57.5%
Operating Margin
7.8%
Net Margin
4.9%
YoY Growth
24.0%
EPS
$0.09
Financial Flow
VIEMED HEALTHCARE, INC. Q3 2025 Financial Summary
VIEMED HEALTHCARE, INC. reported revenue of $71.9M for Q3 2025, with a net profit of $3.5M (4.9% margin). Cost of goods sold was $30.6M, operating expenses totaled $35.7M.
Key Financial Metrics
| Total Revenue | $71.9M |
|---|---|
| Net Profit | $3.5M |
| Gross Margin | 57.5% |
| Operating Margin | 7.8% |
| Report Period | Q3 2025 |
VIEMED HEALTHCARE, INC. Annual Revenue by Year
VIEMED HEALTHCARE, INC. annual revenue history includes year-by-year totals (for example, 2024 revenue was $224.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $224.3M |
| 2023 | $183.0M |
| 2022 | $138.8M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.7M | $50.6M | $55.0M | $58.0M | $60.7M | $59.1M | $63.1M | $71.9M |
| YoY Growth | 35.3% | 27.9% | 26.9% | 17.4% | 19.6% | 16.9% | 14.7% | 24.0% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $154.9M | $154.9M | $163.9M | $169.5M | $177.1M | $178.1M | $184.6M | $202.4M |
| Liabilities | $41.0M | $38.6M | $42.8M | $42.7M | $43.8M | $41.3M | $43.0M | $66.9M |
| Equity | $113.9M | $116.3M | $119.4M | $125.0M | $131.4M | $134.8M | $139.7M | $133.6M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $13.3M | $1.2M | $10.2M | $12.7M | $15.0M | $2.9M | $12.3M | $18.4M |